| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0d2628adf91e1d1316aad5eca927ecd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| filingDate |
1982-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1984-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74fda724bacce7357ce8c418f238454b |
| publicationDate |
1984-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4424202-A |
| titleOfInvention |
Azelaaldehydates as psychotropic agents |
| abstract |
A method for producing a psychotropic response, especially for alleviating the symptoms of alcohol withdrawal, comprises administering to a human or animal subject in need thereof a psychotropically effective non-toxic amount of an azelaaldehydate. A composition for use in the present method is provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3827747-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03009815-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4218718-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010095940-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012044761-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006116718-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2147679-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2392258-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036682-A2 |
| priorityDate |
1982-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |